Recent studies showed that the expression levels of cGAS and STING were inversely correlated with DNA methylation and can be activated by a DNA methyltransferase (DNMT) inhibitor in a subset of colorectal cancer and melanoma cells [12–14], indicating that DNA methylation contributes to silencing of the cGAS-STING pathway. Here, DNMT1 is linked to melanoma.